key: cord-1027893-xlmitdi2
authors: Ramirez‐Hinojosa, Juan Pablo; Rodriguez‐Sanchez, Yunuen; Romero‐Gonzalez, Angel Kaleb; Chavez‐Gutierrez, Marisol; Gonzalez‐Arenas, Nelly Raquel; Ibarra‐Arce, Aurora; Arroyo‐Escalante, Sara; Zavaleta‐Villa, Beatriz; Leon‐Juarez, Moises; Cruz‐Holguin, Victor Javier; Espinosa de los Monteros‐Perez, Luz Elena; Olivo‐Diaz, Angelica; Hernandez‐Castro, Rigoberto; Suarez‐Roa, Lourdes; Prado‐Calleros, Hector; Sierra‐Martinez, Octavio; Avila‐Ramirez, Guillermina; Flisser, Ana; Maravilla, Pablo; Romero‐Valdovinos, Mirza
title: Association between cycle threshold (C (t)) values and clinical and laboratory data in inpatients with COVID‐19 and asymptomatic health workers
date: 2021-07-09
journal: J Med Virol
DOI: 10.1002/jmv.27170
sha: 41f59aeb0b59335abd4d9de3092a2ea50889005f
doc_id: 1027893
cord_uid: xlmitdi2

In‐house assays for the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) by quantitative reverse‐transcription polymerase chain reaction (qRT‐PCR), are feasible alternatives, particularly in developing countries. Cycle threshold (C (t)) values obtained by qRT‐PCR were compared with clinical and laboratory data from saliva of inpatients with COVID‐19 and asymptomatic health workers (AHW) were studied. Saliva specimens from 58 inpatients confirmed by qRT‐PCR for SARS‐CoV‐2 using nasopharyngeal specimens, and 105 AHW were studied by qRT‐PCR using three sets of primers for the N (N1, N2, and N3) gene of SARS‐CoV‐2, according to the CDC Diagnostic Panel protocol, showing a positivity of 88% for inpatients and 8% for AHW. Bivariate analysis revealed an association between C (t) < 38.0 values for N2 and mechanical ventilation assistance among patients (p = .013). In addition, values of aspartate‐transaminase, lactate dehydrogenase, and ferritin showed significant correlations with C (t) values of N1 and N3 genes in inpatients. Therefore, our results show that C (t) values correlate with some relevant clinical data for inpatients with COVID‐19.

Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID- 19) , which has emerged as a global health problem and generated an imminent economic crisis. The World Health Organization (WHO) compiles evidence regarding the transmission of SARS-CoV-2 through direct or indirect contact with infected people that release the virus through body secretions, such as saliva and respiratory secretions or droplets, which are expelled when a person coughs, sneezes, talks or sings by WHO. 1 SARS-CoV and Middle East respiratory syndrome coronavirus RNA can be detected in saliva, 2,3 even before lung damage appear, 2 and saliva has a concordance rate greater than 90% with nasopharyngeal samples in the detection of respiratory viruses. 3 Currently, molecular assays that use self-collected saliva samples are widely available at Rutgers The State University of New Jersey (https://www.rutgers.edu/news/new-rutgers-saliva-test-coronavirusgets-fda-approval). 4 SARS-CoV-2 uses the angiotensin-converting enzyme 2 receptor to enter cells. 5, 6 An in silico study revealed that the expression of this enzyme was higher in minor salivary glands than in the lung. 6 An early study of serial self-collected saliva by patients infected with SARS-CoV-2 showed that 92% (11/12) of saliva samples were positive for the virus. The patients' viral loads were monitored and generally showed a declining trend, leading authors to conclude that saliva sampling could be a promising noninvasive method for diagnosis, monitoring, and control in patients with SARS-CoV-2. 3, 7, 8 An Italian study performed with 25 patients with COVID-19 concluded that saliva is a reliable carrier for detecting SARS-CoV-2. 9 A study performed with 70 inpatients with COVID-19 showed that saliva specimens and nasopharyngeal swabs have similar sensitivity during the course of hospitalization in the detection of SARS-CoV-2 using a primer set from the Centers for Disease Control and Prevention (https://www.fda.gov/media/134919/download). 10 The success of PCR (qRT-PCR) relies on the amplification of tiny amounts of viral genetic material in a sample. A variety of RNA target genes and protocols are now available at World Health Organization (https://apps.who.int/iris/handle/10665/331329), 11 most of which target 1 or more of the envelope (env), nucleocapsid (N), spike (S), RNA-dependent RNA polymerase (RdRp), and ORF1b or ORF8 genes.

In addition, most of the RT-PCR protocols have shown 100% of specificity, since the designed primers are specific to the genome sequence of SARS-CoV-2; however, false-negative results can occur depending on the timing of sample collection in relation to illness onset and due to sampling errors. [12] [13] [14] These techniques have been performed with bronchoalveolar lavage fluid, fibrobronchoscope brush biopsy, sputum, nasal swab, nasopharyngeal swab, saliva, stool, blood and urine, yielding up to 93% positive results depending on the sample studied. [15] [16] [17] In quantitative (q) PCR, a positive reaction is detected as the accumulation of fluorescent signal. Cycle threshold (C t ) is defined as the number of cycles required for the fluorescent signal to cross the threshold, i.e. to exceed the background level. Current qRT-PCR protocols for SARS-CoV-2 detection suggest that samples with C t values less than 40 can be interpreted as positive for viral RNA.

Some authors have argued that a "positive" PCR result during virological load assessment in hospitalized patients reflects only the detection of viral RNA and not necessarily the presence of viable virus. Furthermore, the success of virus isolation by culture has been found to depend on viral load; samples containing less than 10 6 viral copies per ml (or copies per sample) may not yield an isolate. 13, 18 Healthcare workers are at increased risk of exposure to SARS-CoV-2 and potentially influence in-hospital transmission. 19 21 In addition, an alternative to support the diagnosis of SARS-CoV-2 without the use of commercial kits, is the performance of in-house assays. 11 We obtained C t values and compared them with clinical and laboratory data from saliva of inpatients with COVID-19 and asymptomatic health workers (AHW) for the present study.

Participants in this study were hospitalized patients with COVID-19 symptoms who were diagnosed with COVID-19 based on clinical respiratory symptoms and radiological images and confirmed to be infected with SARS-CoV-2 by qRT-PCR using nasopharyngeal specimens following Charité, Germany/WHO protocols by WHO. 11 qRT-PCR confirmation was performed at one of the reference centres in Mexico City (Instituto Nacional de Ciencias Médicas y de la Nutrición "Salvador Zubiran"), with a pneumonia-diagnosis-and-treatment). 22 During admission, clinical and laboratory data were obtained, such as age, sex, comorbidities (hypertension, diabetes, obesity, and previous lung or mediastinal diseases), drugs, inflammatory indexes or tissue damage biomarkers and peripheral blood and biochemistry profiles. 9, 23 In addition, AHW (medical staff, nurses, researchers and administrative personnel) were invited to participate in the study. Approximately 2 ml saliva was obtained from each participant by self-collection; participants spat into sterile 15 ml conical tubes during their hospital admission or in clean, no-COVID-19 areas; for patients in severe/critically ill condition, saliva specimens were obtained using a disposable sterile plastic transfer pipette.

The present study was approved by the Research and Ethics Committees of the "Dr. Manuel Gea Gonzalez" General Hospital with reference number 12-26-2020, and written consent was obtained from all participants or their relatives.

Saliva specimens were frozen at −70°C until processing. An aliquot of 500\ μl saliva was collected, supplemented with 10 µl of 2 M dithiothreitol (DTT) as mucolytic agent and shaken for 30 min. 24 data were plotted versus C t . All saliva samples were analyzed in duplicate with a previously established positive control and saliva from healthy people, which had been stored at −70°C before the COVID-19 pandemic and used as negative controls. In cases where duplicates of a sample yielded C t > 3, the sample was interpreted as inconclusive and analysed again. The lowest C t value for a given sample was selected as the final value.

The SARS-CoV-2 N gene was cloned in the plasmid pProEX HTb Interestingly, the bivariate analysis revealed an association between C t < 38 values for N2 and mechanical ventilation assistance among patients (p = .013).

For three blood biochemistry biomarkers (Figure 1 presented symptoms after their hospital admission and that their C t values (C t = 39) previously were significantly higher than those of symptomatic patients (C t = 34.5). 30 In the present study, we found that patients with COVID-19 exhibited higher C t values than AHW, similarly to C t values described by Kim et al., 27 but in our study, positive AHW were not presymptomatic subjects since they never exhibited symptoms related to COVID-19.

On the other hand, in the present study, the bivariate analysis revealed an association between C t < 38 values for N2 and mechanical ventilation assistance among patients (p = .013), N2 had low C t values (inferring high viral load) with respect to N1 and N3. Interestingly, a retrospective cohort study of 678 inpatients attended in a New York Hospital, showed that the risk of intubation was higher in patients with a high viral load than in those with a medium or low viral load. 31 C t value are inversely related to the viral load, and every~3.3 increase in C t value reflects a 10-fold reduction in starting material. 32 Interestingly, a significant association between C t < 38 for N2 and mechanical ventilation in patients (p = .013) was found, and sig- It has been argued that knowledge of viral load is essential to formulate strategies for antiviral treatment, vaccination, and epidemiological control of COVID-19; however, C t values alone are often used as viral load indicators, which may be a mistake; 35 it is important to consider the viral dynamics, because several reports on viral dynamics indicated that viral shedding peaked on or before symptom onset case after symptoms onset, viral loads decreased; in addition, the variability observed in the C t value that discriminates between infective and noninfective viruses does not allow us to select a single C t value, since this value depends on multiple technical factors (e.g the number and type of target genes). Therefore, a more precise approach to transmissibility would be to jointly evaluate the Finally, the qRT-PCR has high sensitivity and is therefore helpful for the initial diagnosis of COVID-19. 13 However, according to Tom and Mina, 32 reporting the result as a binary measure, i.e., positive or negative, can confuse physicians by eliminating information useful to make decisions. It has been reported that after complete resolution of symptoms, patients infected with SARS-CoV-2 continue to yield positive qRT-PCR results for many weeks. 36 Therefore, it is advisable that clinicians be informed of the C t values obtained during amplification of viral markers as well as C t values corresponding to the assay detection limit of viral RNA, which vary according to the characteristics of each system and amplification protocol used. As Binnicker 37 

The authors declare that there are no conflicts of interests. 

All relevant data are shown within the paper.

The study was conducted in full accordance with ethical principles (World Medical Association Declaration of Helsinki), and written informed consent was obtained from all participants or their relatives. The present study was approved by the Research and Ethics

Committees of the "Dr. Manuel Gea Gonzalez" General Hospital with reference number 12-26-2020.

Pablo Maravilla http://orcid.org/0000-0003-2534-9447

Transmission of SARS-CoV-2: implications for infection prevention precautions

Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis

Additional molecular testing of saliva specimens improves the detection of respiratory viruses

New Rutgers saliva test for coronavirus gets FDA approval

Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

Khademi A Saliva as diagnostic specimen for detection of SARS-CoV-2 in suspected patients: a scoping review

Saliva: potential diagnostic value and transmission of 2019-nCoV

Saliva is a reliable tool to detect SARS-CoV-2

CDC-201-novel coronavirus (2019-nCoV) real-time reverse transcriptase (RT-) PCR diagnostic panel

World Health Organization. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance

False-negative results of initial RT-PCR assays for COVID-19: a systematic review

Interpreting diagnostic tests for SARS-CoV-2

Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China

Assay techniques and test development for COVID-19 diagnosis

Consistent detection of 2019 novel coronavirus in saliva

Detection of SARS-CoV-2 in different types of clinical specimens

Virological assessment of hospitalized patients with COVID-2019

COVID-19 in healthcare workers in three hospitals in the south of the Netherlands: a cross-sectional study

Characteristics and outcomes of health and social care workers testing positive for SARS-CoV-2 in the Tayside region of Scotland

Chinese National Health Commission. Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment

Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis

Improving geneexpression studies from sputum: a multistep optimization of RNA isolation and qPCR protocols

Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients

Patterns of viral clearance in the natural course of asymptomatic COVID-19: Comparison with symptomatic non-severe COVID-19

Asymptomatic infection by SARS 2 coronavirus: Invisible but invincible" by Nikolai et al. 2020

SARS-CoV-2 y RT-PCR en pacientes asintomáticos: resultados de una cohorte de trabajadores del Aeropuerto Internacional El Dorado de Bogotá

Impact of SARS-CoV-2 viral load on risk of intubation and mortality among hospitalized patients with coronavirus disease 2019

To Interpret the SARS-CoV-2 test, consider the cycle threshold value

Ferritin levels and COVID-19

Utility of ferritin, procalcitonin, and C-reactive protein in severe patients with 2019 novel coronavirus disease

Misinterpretation of viral load in COVID-19 clinical outcomes

Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients

Can the SARS-CoV-2 PCR cycle threshold value and time from symptom onset to testing predict infectivity?

Association between cycle threshold (C t ) values and clinical and laboratory data in inpatients with COVID-19 and asymptomatic health workers